Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Intellia Therapeutics Inc, Common Stock

NTLA

NMQ

$20.76

+$0.74

(3.7%)

Industry: Biotechnology Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$2.00B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

1.03M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

1.21M

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.80

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$19.64 L

$47.48 H

$20.76

About Intellia Therapeutics Inc, Common Stock

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time Frame	NTLA	Sector	S&P500
1-Week Return	-3.76%	0.71%	1.64%
1-Month Return	-20.94%	-4%	-2.94%
3-Month Return	-15.88%	0.84%	3.53%
6-Month Return	-16.96%	12.62%	22.95%
1-Year Return	-42.7%	7.99%	26.43%
3-Year Return	-75.52%	18.97%	26.19%
5-Year Return	21.83%	71.39%	86.42%
10-Year Return	-6.06%	184.83%	224.48%

Time Frame	NTLA	Sector	S&P500
1-Week Return	-86.44%	44.62%	133.55%
1-Month Return	-94.27%	-39.14%	-30.45%
3-Month Return	-50.41%	3.45%	15.11%
6-Month Return	-31.40%	27.25%	52.04%
1-Year Return	-42.70%	7.99%	26.43%
3-Year Return	-37.44%	5.96%	8.06%
5-Year Return	4.03%	11.38%	13.27%
10-Year Return	-0.62%	11.03%	12.49%

Financials

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	43.10M	57.99M	33.05M	52.12M	36.27M	[{"date":"2019-12-31","value":74.32,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":56.99,"profit":true},{"date":"2022-12-31","value":89.87,"profit":true},{"date":"2023-12-31","value":62.55,"profit":true}]
Cost of Revenue	108.41M	150.41M	6.89M	7.57M	8.98M	[{"date":"2019-12-31","value":72.08,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":4.58,"profit":true},{"date":"2022-12-31","value":5.03,"profit":true},{"date":"2023-12-31","value":5.97,"profit":true}]
Gross Profit	(65.31M)	57.99M	33.05M	44.55M	27.30M	[{"date":"2019-12-31","value":-112.62,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":56.99,"profit":true},{"date":"2022-12-31","value":76.82,"profit":true},{"date":"2023-12-31","value":47.07,"profit":true}]
Gross Margin	(151.52%)	100.00%	100.00%	85.47%	75.26%	[{"date":"2019-12-31","value":-151.52,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":85.47,"profit":true},{"date":"2023-12-31","value":75.26,"profit":true}]

Operating Expenses	149.47M	194.58M	300.90M	510.29M	551.57M	[{"date":"2019-12-31","value":27.1,"profit":true},{"date":"2020-12-31","value":35.28,"profit":true},{"date":"2021-12-31","value":54.55,"profit":true},{"date":"2022-12-31","value":92.52,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	(106.37M)	(136.58M)	(267.85M)	(458.16M)	(515.29M)	[{"date":"2019-12-31","value":-10636800000,"profit":false},{"date":"2020-12-31","value":-13658300000,"profit":false},{"date":"2021-12-31","value":-26785000000,"profit":false},{"date":"2022-12-31","value":-45816400000,"profit":false},{"date":"2023-12-31","value":-51529100000,"profit":false}]
Total Non-Operating Income/Expense	13.67M	4.70M	1.24M	(7.48M)	34.10M	[{"date":"2019-12-31","value":40.09,"profit":true},{"date":"2020-12-31","value":13.8,"profit":true},{"date":"2021-12-31","value":3.64,"profit":true},{"date":"2022-12-31","value":-21.94,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	(99.53M)	(134.23M)	(267.89M)	(474.19M)	(481.19M)	[{"date":"2019-12-31","value":-9953300000,"profit":false},{"date":"2020-12-31","value":-13423100000,"profit":false},{"date":"2021-12-31","value":-26789200000,"profit":false},{"date":"2022-12-31","value":-47418600000,"profit":false},{"date":"2023-12-31","value":-48119200000,"profit":false}]
Income Taxes	(6.83M)	(8.66M)	(8.17M)	16.02M	(49.73M)	[{"date":"2019-12-31","value":-42.66,"profit":false},{"date":"2020-12-31","value":-54.07,"profit":false},{"date":"2021-12-31","value":-51.02,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-310.4,"profit":false}]
Income After Taxes	(92.70M)	(125.57M)	(259.72M)	(490.21M)	(431.46M)	[{"date":"2019-12-31","value":-9269800000,"profit":false},{"date":"2020-12-31","value":-12556800000,"profit":false},{"date":"2021-12-31","value":-25971800000,"profit":false},{"date":"2022-12-31","value":-49020800000,"profit":false},{"date":"2023-12-31","value":-43146000000,"profit":false}]

Income From Continuous Operations	(99.53M)	(134.49M)	(267.81M)	(474.19M)	(481.19M)	[{"date":"2019-12-31","value":-9953300000,"profit":false},{"date":"2020-12-31","value":-13449100000,"profit":false},{"date":"2021-12-31","value":-26780800000,"profit":false},{"date":"2022-12-31","value":-47418600000,"profit":false},{"date":"2023-12-31","value":-48119200000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(92.70M)	(125.57M)	(259.72M)	(490.21M)	(481.19M)	[{"date":"2019-12-31","value":-9269800000,"profit":false},{"date":"2020-12-31","value":-12556800000,"profit":false},{"date":"2021-12-31","value":-25971800000,"profit":false},{"date":"2022-12-31","value":-49020800000,"profit":false},{"date":"2023-12-31","value":-48119200000,"profit":false}]

EPS (Diluted)	(2.11)	(2.40)	(3.76)	(6.18)	(5.41)	[{"date":"2019-12-31","value":-211,"profit":false},{"date":"2020-12-31","value":-240,"profit":false},{"date":"2021-12-31","value":-376,"profit":false},{"date":"2022-12-31","value":-618,"profit":false},{"date":"2023-12-31","value":-541,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	-	34.55%	(43.01%)	57.69%	(30.40%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":59.89,"profit":true},{"date":"2021-12-31","value":-74.55,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-52.7,"profit":false}]
Cost of Revenue	-	38.74%	(95.42%)	9.88%	18.54%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-246.33,"profit":false},{"date":"2022-12-31","value":25.51,"profit":true},{"date":"2023-12-31","value":47.87,"profit":true}]
Gross Profit	-	(188.80%)	(43.01%)	34.78%	(38.72%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-542.83,"profit":false},{"date":"2021-12-31","value":-123.65,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-111.33,"profit":false}]
Gross Margin	-	(166.00%)	-	(14.53%)	(11.95%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Operating Expenses	-	30.18%	54.64%	69.58%	8.09%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":43.37,"profit":true},{"date":"2021-12-31","value":78.53,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":11.63,"profit":true}]
Operating Income	-	28.41%	96.11%	71.05%	12.47%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":29.56,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":73.93,"profit":true},{"date":"2023-12-31","value":12.97,"profit":true}]
Total Non-Operating Income/Expense	-	(65.59%)	(73.62%)	(702.74%)	(555.87%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Pre-Tax Income	-	34.86%	99.58%	77.01%	1.48%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":35.01,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":77.33,"profit":true},{"date":"2023-12-31","value":1.48,"profit":true}]
Income Taxes	-	26.74%	(5.64%)	(296.01%)	(410.40%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-21.11,"profit":false},{"date":"2022-12-31","value":-1106.81,"profit":false},{"date":"2023-12-31","value":-1534.5,"profit":false}]
Income After Taxes	-	35.46%	106.83%	88.75%	(11.98%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":33.19,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":83.07,"profit":true},{"date":"2023-12-31","value":-11.22,"profit":false}]

Income From Continuous Operations	-	35.12%	99.13%	77.06%	1.48%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":35.43,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":77.74,"profit":true},{"date":"2023-12-31","value":1.49,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	35.46%	106.83%	88.75%	(1.84%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":33.19,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":83.07,"profit":true},{"date":"2023-12-31","value":-1.72,"profit":false}]

EPS (Diluted)	-	13.74%	56.67%	64.36%	(12.46%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":21.35,"profit":true},{"date":"2021-12-31","value":88.04,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-19.36,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Revenue	13.57M	12.61M	13.59M	11.99M	(1.92M)	[{"date":"2022-12-31","value":99.85,"profit":true},{"date":"2023-03-31","value":92.73,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":88.22,"profit":true},{"date":"2023-12-31","value":-14.1,"profit":false}]
Cost of Revenue	2.03M	2.05M	2.17M	2.29M	2.47M	[{"date":"2022-12-31","value":82.36,"profit":true},{"date":"2023-03-31","value":83.13,"profit":true},{"date":"2023-06-30","value":88,"profit":true},{"date":"2023-09-30","value":92.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit	11.54M	10.56M	11.42M	9.70M	(4.38M)	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":91.46,"profit":true},{"date":"2023-06-30","value":98.98,"profit":true},{"date":"2023-09-30","value":84.06,"profit":true},{"date":"2023-12-31","value":-37.97,"profit":false}]
Gross Margin	85.04%	83.74%	84.04%	80.90%	228.64%	[{"date":"2022-12-31","value":37.19,"profit":true},{"date":"2023-03-31","value":36.62,"profit":true},{"date":"2023-06-30","value":36.76,"profit":true},{"date":"2023-09-30","value":35.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	123.66M	124.56M	145.93M	143.10M	137.97M	[{"date":"2022-12-31","value":84.74,"profit":true},{"date":"2023-03-31","value":85.36,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":98.06,"profit":true},{"date":"2023-12-31","value":94.55,"profit":true}]
Operating Income	(110.09M)	(111.96M)	(132.33M)	(131.11M)	(139.89M)	[{"date":"2022-12-31","value":-11008700000,"profit":false},{"date":"2023-03-31","value":-11195800000,"profit":false},{"date":"2023-06-30","value":-13233400000,"profit":false},{"date":"2023-09-30","value":-13110700000,"profit":false},{"date":"2023-12-31","value":-13989200000,"profit":false}]
Total Non-Operating Income/Expense	2.03M	20.81M	8.65M	8.88M	7.73M	[{"date":"2022-12-31","value":9.77,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":41.58,"profit":true},{"date":"2023-09-30","value":42.68,"profit":true},{"date":"2023-12-31","value":37.15,"profit":true}]
Pre-Tax Income	(113.41M)	(103.13M)	(123.68M)	(122.22M)	(132.16M)	[{"date":"2022-12-31","value":-11340700000,"profit":false},{"date":"2023-03-31","value":-10312600000,"profit":false},{"date":"2023-06-30","value":-12368100000,"profit":false},{"date":"2023-09-30","value":-12222400000,"profit":false},{"date":"2023-12-31","value":-13216100000,"profit":false}]
Income Taxes	3.32M	(10.78M)	(14.82M)	(15.03M)	40.63M	[{"date":"2022-12-31","value":8.17,"profit":true},{"date":"2023-03-31","value":-26.53,"profit":false},{"date":"2023-06-30","value":-36.48,"profit":false},{"date":"2023-09-30","value":-36.99,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes	(116.73M)	(92.34M)	(108.86M)	(107.19M)	(172.80M)	[{"date":"2022-12-31","value":-11672700000,"profit":false},{"date":"2023-03-31","value":-9234400000,"profit":false},{"date":"2023-06-30","value":-10885800000,"profit":false},{"date":"2023-09-30","value":-10719400000,"profit":false},{"date":"2023-12-31","value":-17279600000,"profit":false}]

Income From Continuous Operations	(113.41M)	(100.14M)	(123.68M)	(122.22M)	(132.16M)	[{"date":"2022-12-31","value":-11340700000,"profit":false},{"date":"2023-03-31","value":-10013700000,"profit":false},{"date":"2023-06-30","value":-12368100000,"profit":false},{"date":"2023-09-30","value":-12222400000,"profit":false},{"date":"2023-12-31","value":-13216100000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(116.73M)	(92.34M)	(123.68M)	(122.22M)	(132.16M)	[{"date":"2022-12-31","value":-11672700000,"profit":false},{"date":"2023-03-31","value":-9234400000,"profit":false},{"date":"2023-06-30","value":-12368100000,"profit":false},{"date":"2023-09-30","value":-12222400000,"profit":false},{"date":"2023-12-31","value":-13216100000,"profit":false}]

EPS (Diluted)	(1.40)	(1.17)	(1.40)	(1.38)	(1.46)	[{"date":"2022-12-31","value":-140,"profit":false},{"date":"2023-03-31","value":-117,"profit":false},{"date":"2023-06-30","value":-140,"profit":false},{"date":"2023-09-30","value":-138,"profit":false},{"date":"2023-12-31","value":-146,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Revenue	-	(7.12%)	7.84%	(11.78%)	(115.99%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-90.9,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-150.36,"profit":false},{"date":"2023-12-31","value":-1479.87,"profit":false}]
Cost of Revenue	-	0.94%	5.85%	5.53%	7.69%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":12.17,"profit":true},{"date":"2023-06-30","value":76.16,"profit":true},{"date":"2023-09-30","value":71.95,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit	-	(8.54%)	8.22%	(15.07%)	(145.18%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-103.89,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-183.31,"profit":false},{"date":"2023-12-31","value":-1765.53,"profit":false}]
Gross Margin	-	(1.53%)	0.36%	(3.73%)	182.60%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-0.84,"profit":false},{"date":"2023-06-30","value":0.2,"profit":true},{"date":"2023-09-30","value":-2.04,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	-	0.73%	17.15%	(1.94%)	(3.58%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":4.26,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-11.3,"profit":false},{"date":"2023-12-31","value":-20.88,"profit":false}]
Operating Income	-	1.70%	18.20%	(0.93%)	6.70%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":9.34,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-5.09,"profit":false},{"date":"2023-12-31","value":36.82,"profit":true}]
Total Non-Operating Income/Expense	-	923.21%	(58.42%)	2.66%	(12.97%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-6.33,"profit":false},{"date":"2023-09-30","value":0.29,"profit":true},{"date":"2023-12-31","value":-1.4,"profit":false}]
Pre-Tax Income	-	(9.07%)	19.93%	(1.18%)	8.13%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-45.48,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-5.91,"profit":false},{"date":"2023-12-31","value":40.79,"profit":true}]
Income Taxes	-	(424.76%)	37.48%	1.40%	(370.36%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-1133.32,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":3.73,"profit":true},{"date":"2023-12-31","value":-988.17,"profit":false}]
Income After Taxes	-	(20.89%)	17.88%	(1.53%)	61.20%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-34.13,"profit":false},{"date":"2023-06-30","value":29.22,"profit":true},{"date":"2023-09-30","value":-2.5,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Income From Continuous Operations	-	(11.70%)	23.51%	(1.18%)	8.13%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-49.77,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-5.01,"profit":false},{"date":"2023-12-31","value":34.58,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(20.89%)	33.94%	(1.18%)	8.13%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-61.56,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-3.47,"profit":false},{"date":"2023-12-31","value":23.96,"profit":true}]

EPS (Diluted)	-	(16.43%)	19.66%	(1.43%)	5.80%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-83.57,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-7.27,"profit":false},{"date":"2023-12-31","value":29.49,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	289.48M	597.37M	769.30M	1.22B	998.33M	[{"date":"2019-12-31","value":23.79,"profit":true},{"date":"2020-12-31","value":49.09,"profit":true},{"date":"2021-12-31","value":63.22,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.05,"profit":true}]
Non-current Assets	44.80M	78.95M	525.16M	303.32M	302.65M	[{"date":"2019-12-31","value":8.53,"profit":true},{"date":"2020-12-31","value":15.03,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":57.76,"profit":true},{"date":"2023-12-31","value":57.63,"profit":true}]
Total Assets	334.28M	676.32M	1.29B	1.52B	1.30B	[{"date":"2019-12-31","value":21.99,"profit":true},{"date":"2020-12-31","value":44.49,"profit":true},{"date":"2021-12-31","value":85.16,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.58,"profit":true}]

Total Liabilities
Current Liabilities	35.63M	64.25M	125.83M	126.55M	115.21M	[{"date":"2019-12-31","value":28.16,"profit":true},{"date":"2020-12-31","value":50.77,"profit":true},{"date":"2021-12-31","value":99.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.03,"profit":true}]
Non-current Liabilities	28.77M	85.00M	128.39M	157.98M	135.60M	[{"date":"2019-12-31","value":18.21,"profit":true},{"date":"2020-12-31","value":53.8,"profit":true},{"date":"2021-12-31","value":81.27,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.84,"profit":true}]
Total Liabilities	64.40M	149.25M	254.22M	284.53M	250.81M	[{"date":"2019-12-31","value":22.63,"profit":true},{"date":"2020-12-31","value":52.45,"profit":true},{"date":"2021-12-31","value":89.35,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.15,"profit":true}]

Total Shareholders' equity
Common Stock	5.00K	7.00K	7.00K	9.00K	9.00K	[{"date":"2019-12-31","value":55.56,"profit":true},{"date":"2020-12-31","value":77.78,"profit":true},{"date":"2021-12-31","value":77.78,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	(300.88M)	(435.11M)	(703.00M)	(1.18B)	(1.66B)	[{"date":"2019-12-31","value":-30087800000,"profit":false},{"date":"2020-12-31","value":-43510900000,"profit":false},{"date":"2021-12-31","value":-70300100000,"profit":false},{"date":"2022-12-31","value":-117718700000,"profit":false},{"date":"2023-12-31","value":-165837900000,"profit":false}]
Other Stockholders' Equity	570.49M	962.17M	1.75B	2.42B	2.71B	[{"date":"2019-12-31","value":21.05,"profit":true},{"date":"2020-12-31","value":35.49,"profit":true},{"date":"2021-12-31","value":64.4,"profit":true},{"date":"2022-12-31","value":89.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	269.88M	527.07M	1.04B	1.24B	1.05B	[{"date":"2019-12-31","value":21.84,"profit":true},{"date":"2020-12-31","value":42.66,"profit":true},{"date":"2021-12-31","value":84.19,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":84.99,"profit":true}]

Total Liabilities & Shareholders Equity	334.28M	676.32M	1.29B	1.52B	1.30B	[{"date":"2019-12-31","value":21.99,"profit":true},{"date":"2020-12-31","value":44.49,"profit":true},{"date":"2021-12-31","value":85.16,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.58,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	-	106.36%	28.78%	58.17%	(17.95%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":27.06,"profit":true},{"date":"2022-12-31","value":54.69,"profit":true},{"date":"2023-12-31","value":-16.88,"profit":false}]
Non-current Assets	-	76.23%	565.17%	(42.24%)	(0.22%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":13.49,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-7.47,"profit":false},{"date":"2023-12-31","value":-0.04,"profit":false}]
Total Assets	-	102.32%	91.40%	17.43%	(14.42%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":89.32,"profit":true},{"date":"2022-12-31","value":17.04,"profit":true},{"date":"2023-12-31","value":-14.09,"profit":false}]

Total Liabilities
Current Liabilities	-	80.32%	95.84%	0.57%	(8.97%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":83.81,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.6,"profit":true},{"date":"2023-12-31","value":-9.35,"profit":false}]
Non-current Liabilities	-	195.47%	51.05%	23.05%	(14.16%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":26.12,"profit":true},{"date":"2022-12-31","value":11.79,"profit":true},{"date":"2023-12-31","value":-7.25,"profit":false}]
Total Liabilities	-	131.76%	70.33%	11.92%	(11.85%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":53.38,"profit":true},{"date":"2022-12-31","value":9.05,"profit":true},{"date":"2023-12-31","value":-9,"profit":false}]

Total Shareholders' equity
Common Stock	-	40.00%	-	28.57%	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":71.43,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	44.61%	61.57%	67.45%	40.88%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":66.14,"profit":true},{"date":"2021-12-31","value":91.28,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":60.6,"profit":true}]
Other Stockholders' Equity	-	68.66%	81.45%	38.63%	12.01%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":84.29,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":47.42,"profit":true},{"date":"2023-12-31","value":14.74,"profit":true}]
Total Shareholders' equity	-	95.30%	97.36%	18.78%	(15.01%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":97.88,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":19.29,"profit":true},{"date":"2023-12-31","value":-15.41,"profit":false}]

Total Liabilities & Shareholders Equity	-	102.32%	91.40%	17.43%	(14.42%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":89.32,"profit":true},{"date":"2022-12-31","value":17.04,"profit":true},{"date":"2023-12-31","value":-14.09,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Assets
Current Assets	1.22B	963.67M	939.62M	893.49M	998.33M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":79.2,"profit":true},{"date":"2023-06-30","value":77.22,"profit":true},{"date":"2023-09-30","value":73.43,"profit":true},{"date":"2023-12-31","value":82.05,"profit":true}]
Non-current Assets	303.32M	454.22M	383.63M	349.86M	302.65M	[{"date":"2022-12-31","value":66.78,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":84.46,"profit":true},{"date":"2023-09-30","value":77.02,"profit":true},{"date":"2023-12-31","value":66.63,"profit":true}]
Total Assets	1.52B	1.42B	1.32B	1.24B	1.30B	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":93.28,"profit":true},{"date":"2023-06-30","value":87.05,"profit":true},{"date":"2023-09-30","value":81.79,"profit":true},{"date":"2023-12-31","value":85.58,"profit":true}]

Total Liabilities
Current Liabilities	126.55M	103.38M	99.85M	91.95M	115.21M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":81.69,"profit":true},{"date":"2023-06-30","value":78.9,"profit":true},{"date":"2023-09-30","value":72.66,"profit":true},{"date":"2023-12-31","value":91.03,"profit":true}]
Non-current Liabilities	157.98M	123.66M	118.50M	113.98M	135.60M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":78.28,"profit":true},{"date":"2023-06-30","value":75.01,"profit":true},{"date":"2023-09-30","value":72.15,"profit":true},{"date":"2023-12-31","value":85.84,"profit":true}]
Total Liabilities	284.53M	227.05M	218.35M	205.94M	250.81M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":79.8,"profit":true},{"date":"2023-06-30","value":76.74,"profit":true},{"date":"2023-09-30","value":72.38,"profit":true},{"date":"2023-12-31","value":88.15,"profit":true}]

Total Shareholders' equity
Common Stock	9.00K	9.00K	9.00K	9.00K	9.00K	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	(1.18B)	(1.28B)	(1.40B)	(1.53B)	(1.66B)	[{"date":"2022-12-31","value":-117718700000,"profit":false},{"date":"2023-03-31","value":-128031300000,"profit":false},{"date":"2023-06-30","value":-140399400000,"profit":false},{"date":"2023-09-30","value":-152621800000,"profit":false},{"date":"2023-12-31","value":-165837900000,"profit":false}]
Other Stockholders' Equity	2.42B	2.47B	2.51B	2.57B	2.71B	[{"date":"2022-12-31","value":89.28,"profit":true},{"date":"2023-03-31","value":91.26,"profit":true},{"date":"2023-06-30","value":92.69,"profit":true},{"date":"2023-09-30","value":94.7,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	1.24B	1.19B	1.10B	1.04B	1.05B	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":96.38,"profit":true},{"date":"2023-06-30","value":89.42,"profit":true},{"date":"2023-09-30","value":83.96,"profit":true},{"date":"2023-12-31","value":84.99,"profit":true}]

Total Liabilities & Shareholders Equity	1.52B	1.42B	1.32B	1.24B	1.30B	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":93.28,"profit":true},{"date":"2023-06-30","value":87.05,"profit":true},{"date":"2023-09-30","value":81.79,"profit":true},{"date":"2023-12-31","value":85.58,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Assets
Current Assets	-	(20.80%)	(2.50%)	(4.91%)	11.73%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-177.29,"profit":false},{"date":"2023-06-30","value":-21.28,"profit":false},{"date":"2023-09-30","value":-41.83,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	49.75%	(15.54%)	(8.80%)	(13.49%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-31.24,"profit":false},{"date":"2023-09-30","value":-17.69,"profit":false},{"date":"2023-12-31","value":-27.12,"profit":false}]
Total Assets	-	(6.72%)	(6.68%)	(6.04%)	4.63%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-145.09,"profit":false},{"date":"2023-06-30","value":-144.02,"profit":false},{"date":"2023-09-30","value":-130.26,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	(18.31%)	(3.42%)	(7.91%)	25.29%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-72.4,"profit":false},{"date":"2023-06-30","value":-13.51,"profit":false},{"date":"2023-09-30","value":-31.28,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	-	(21.72%)	(4.17%)	(3.81%)	18.97%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-114.52,"profit":false},{"date":"2023-06-30","value":-22.01,"profit":false},{"date":"2023-09-30","value":-20.11,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	(20.20%)	(3.83%)	(5.69%)	21.79%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-92.72,"profit":false},{"date":"2023-06-30","value":-17.57,"profit":false},{"date":"2023-09-30","value":-26.1,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	8.76%	9.66%	8.71%	8.66%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":90.69,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":90.12,"profit":true},{"date":"2023-12-31","value":89.64,"profit":true}]
Other Stockholders' Equity	-	2.21%	1.57%	2.17%	5.59%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":39.59,"profit":true},{"date":"2023-06-30","value":28.12,"profit":true},{"date":"2023-09-30","value":38.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	(3.62%)	(7.22%)	(6.11%)	1.23%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-294.51,"profit":false},{"date":"2023-06-30","value":-587.07,"profit":false},{"date":"2023-09-30","value":-496.7,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(6.72%)	(6.68%)	(6.04%)	4.63%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-145.09,"profit":false},{"date":"2023-06-30","value":-144.02,"profit":false},{"date":"2023-09-30","value":-130.26,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	(103.24M)	(49.91M)	(225.03M)	(333.29M)	(394.09M)	[{"date":"2019-12-31","value":-10324000000,"profit":false},{"date":"2020-12-31","value":-4991200000,"profit":false},{"date":"2021-12-31","value":-22503000000,"profit":false},{"date":"2022-12-31","value":-33328700000,"profit":false},{"date":"2023-12-31","value":-39408600000,"profit":false}]

Investing Activities
Net Investing Cash Flow	25.18M	(214.49M)	(550.78M)	160.31M	-	[{"date":"2019-12-31","value":15.7,"profit":true},{"date":"2020-12-31","value":-133.8,"profit":false},{"date":"2021-12-31","value":-343.57,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	76.43M	371.78M	736.69M	582.96M	130.32M	[{"date":"2019-12-31","value":10.38,"profit":true},{"date":"2020-12-31","value":50.47,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":79.13,"profit":true},{"date":"2023-12-31","value":17.69,"profit":true}]

Net Change in Cash	(1.63M)	107.38M	(39.12M)	409.98M	(295.11M)	[{"date":"2019-12-31","value":-0.4,"profit":false},{"date":"2020-12-31","value":26.19,"profit":true},{"date":"2021-12-31","value":-9.54,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-71.98,"profit":false}]

Free Cash Flow
Free Cash Flow	(110.03M)	(53.50M)	(237.79M)	(391.68M)	(408.07M)	[{"date":"2019-12-31","value":-11003400000,"profit":false},{"date":"2020-12-31","value":-5349700000,"profit":false},{"date":"2021-12-31","value":-23778600000,"profit":false},{"date":"2022-12-31","value":-39167700000,"profit":false},{"date":"2023-12-31","value":-40807100000,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(51.65%)	350.85%	48.11%	18.24%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-14.72,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":13.71,"profit":true},{"date":"2023-12-31","value":5.2,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(951.95%)	156.79%	(129.11%)	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-607.16,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-82.34,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	386.41%	98.15%	(20.87%)	(77.64%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":25.4,"profit":true},{"date":"2022-12-31","value":-5.4,"profit":false},{"date":"2023-12-31","value":-20.09,"profit":false}]

Net Change in Cash	-	(6687.73%)	(136.43%)	(1148.00%)	(171.98%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(51.38%)	344.48%	64.72%	4.19%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-14.92,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":18.79,"profit":true},{"date":"2023-12-31","value":1.22,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Operating Activities
Net Operating Cash Flow	(89.87M)	(109.33M)	(90.32M)	(101.38M)	(93.05M)	[{"date":"2022-12-31","value":-8986900000,"profit":false},{"date":"2023-03-31","value":-10932800000,"profit":false},{"date":"2023-06-30","value":-9032300000,"profit":false},{"date":"2023-09-30","value":-10138100000,"profit":false},{"date":"2023-12-31","value":-9305400000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(30.15M)	(122.25M)	(34.54M)	-	-	[{"date":"2022-12-31","value":-3015200000,"profit":false},{"date":"2023-03-31","value":-12224800000,"profit":false},{"date":"2023-06-30","value":-3453800000,"profit":false},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	505.76M	2.22M	2.52M	19.10M	106.48M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":0.44,"profit":true},{"date":"2023-06-30","value":0.5,"profit":true},{"date":"2023-09-30","value":3.78,"profit":true},{"date":"2023-12-31","value":21.05,"profit":true}]

Net Change in Cash	385.74M	(229.35M)	(122.34M)	(2.78M)	59.37M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":-59.46,"profit":false},{"date":"2023-06-30","value":-31.72,"profit":false},{"date":"2023-09-30","value":-0.72,"profit":false},{"date":"2023-12-31","value":15.39,"profit":true}]

Free Cash Flow
Free Cash Flow	(93.78M)	(113.16M)	(94.62M)	(105.71M)	(94.57M)	[{"date":"2022-12-31","value":-9378100000,"profit":false},{"date":"2023-03-31","value":-11316000000,"profit":false},{"date":"2023-06-30","value":-9462400000,"profit":false},{"date":"2023-09-30","value":-10571300000,"profit":false},{"date":"2023-12-31","value":-9457400000,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Operating Activities
Net Operating Cash Flow	-	21.65%	(17.38%)	12.24%	(8.21%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-80.28,"profit":false},{"date":"2023-09-30","value":56.54,"profit":true},{"date":"2023-12-31","value":-37.93,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	305.44%	(71.75%)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-23.49,"profit":false},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(99.56%)	13.28%	659.22%	457.45%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-15.1,"profit":false},{"date":"2023-06-30","value":2.01,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":69.39,"profit":true}]

Net Change in Cash	-	(159.46%)	(46.66%)	(97.73%)	(2236.34%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":null,"profit":false},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	20.66%	(16.38%)	11.72%	(10.54%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-79.27,"profit":false},{"date":"2023-09-30","value":56.71,"profit":true},{"date":"2023-12-31","value":-50.99,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	NTLA
Cash Ratio	7.92
Current Ratio	8.67

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	NTLA
ROA (LTM)	-22.83%
ROE (LTM)	-42.10%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	NTLA
Debt Ratio Lower is generally better. Negative is bad.	0.19
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.81
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is.	1.24

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	NTLA
Trailing PE	NM
Forward PE	NM
P/S (TTM)	64.30
P/B	2.22
Price/FCF	NM
EV/R	42.39
EV/Ebitda	NM
PEG	NM

News

Intellia Therapeutics Welcomes New Principal Accounting Officer

Intellia Therapeutics (NTLA) has provided an update. Intellia Therapeutics has appointed Michael P. Dube as the new principal accounting officer. W…

15 Apr, 2024 a 8:32 pm TipRanks

Better Cathie Wood Stock: Moderna vs. Intellia

Moderna and Intellia have declined in the double digits over the past year.

28 Mar, 2024 a 9:55 am The Motley Fool

Intellia Ends Gene Editing Deal with Regeneron Pharmaceuticals

Intellia Therapeutics (NTLA) has shared an update. Intellia Therapeutics has decided to withdraw from its 2020 collaboration with Regeneron Pharmac…

22 Mar, 2024 a 1:42 pm TipRanks

Hot Stocks: The 3 Best Opportunities for Investing in Biotech

When it comes to risk vs. reward in the stock market, the biotech sector has one of the highest potential payoffs. Many a fortune has been made after successful clinical results or a timely FDA approval for a new drug. Following a company’s progress from research to approval can be a life-changing way to invest. At the same time, biotech companies can fail during a clinical trial or get denied by the FDA. In the biotech sector, this type of failure can set a company back years or worse, send them into bankruptcy. Like any industry, there are biotech leaders as well and you’ll read about two of them in this article. These 3 biotech stocks offer incredible potential for any long-term, well-diversified portfolio. Novo Nordisk A/S (NVO) Source: joreks / Shutterstock.com Novo Nordisk A/S (NYSE: NVO ) is a Danish multinational biotech company that was founded in 1923. It is the most valuable biotech company in Europe and its market capitalization has surpassed the annual GDP of Denmark. As an ADR, NVO trades on the New York Stock Exchange but its home exchange is in Copenhagen.

21 Mar, 2024 a 9:29 pm InvestorPlace

3 Stocks That Could Be the Next Big Thing in Gene Editing

Gene editing could revolutionize how millions of patients are treated all over the world. That could create big opportunities for some of the most exciting gene-editing stocks. Look at gene editing stocks, like CRISPR Therapeutics (NASDAQ: CRSP ), for example. Several weeks ago, the U.S. Federal Drug Administration approved a new gene-editing treatment for sickle cell disease and transfusion-dependent beta-thalassemia, a genetic disorder that prevents the production of hemoglobin in the blood. Since then, CRSP has run from about $40 to a high of $90. Now back to $72.94, it’s oversold and could easily rally back to $90 soon. In fact, with a pipeline full of other potential treatments for immune-oncology, autoimmune diseases, cardiovascular disease and Type 1 diabetes, the CRSP stock could race higher. Plus, with gene editing gaining major traction, the market could be worth about $29.9 billion by the time 2032 rolls around, as noted by Precedence Research. Even better, there are plenty of other gene-editing stocks with similar potential.

21 Mar, 2024 a 8:19 pm InvestorPlace

Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy | NTLA Stock News

Intellia Therapeutics, Inc. announces the dosing of the first patient in the global pivotal Phase 3 MAGNITUDE trial of NTLA-2001, an in vivo CRISPR-based therapy for transthyretin amyloidosis. Positive Phase 1 results showed deep and durable reductions in the TTR protein. The trial aims to evaluate efficacy and safety in patients with cardiomyopathy, potentially revolutionizing treatment for ATTR amyloidosis.

18 Mar, 2024 a 11:30 am Stock Titan

Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy

CAMBRIDGE, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced the first patient dosed in the global pivotal, Phase 3 MAGNITUDE trial of NTLA-2001. NTLA-2001 is an investigational in vivo CRISPR-based therapy designed as a single-dose treatment to inactivate the TTR gene and thereby prevent the production of TTR protein for the treatment of transthyretin (ATTR) amyloidosis. The MAGNITUDE trial is evaluating the efficacy and safety of NTLA-2001 in patients with ATTR amyloidosis with cardiomyopathy.

18 Mar, 2024 a 11:30 am GlobeNewswire

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Intellia Therapeutics Inc share price today?

Intellia Therapeutics Inc (NTLA) share price today is $20.76

Can Indians buy Intellia Therapeutics Inc shares?

Yes, Indians can buy shares of Intellia Therapeutics Inc (NTLA) on Vested. To buy Intellia Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NTLA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Intellia Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Intellia Therapeutics Inc (NTLA) via the Vested app. You can start investing in Intellia Therapeutics Inc (NTLA) with a minimum investment of $1.

How to invest in Intellia Therapeutics Inc shares from India?

You can invest in shares of Intellia Therapeutics Inc (NTLA) via Vested in three simple steps:

Click on Sign Up or Invest in NTLA stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Intellia Therapeutics Inc shares

What is Intellia Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Intellia Therapeutics Inc (NTLA) is $47.48. The 52-week low price of Intellia Therapeutics Inc (NTLA) is $19.64.

What is Intellia Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Intellia Therapeutics Inc (NTLA) is NM

What is Intellia Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Intellia Therapeutics Inc (NTLA) is 2.22

What is Intellia Therapeutics Inc dividend yield?

The dividend yield of Intellia Therapeutics Inc (NTLA) is 0.00%

What is the Market Cap of Intellia Therapeutics Inc?

The market capitalization of Intellia Therapeutics Inc (NTLA) is $2.00B

What is Intellia Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Intellia Therapeutics Inc is NTLA

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Global

India

Intellia Therapeutics Inc, Common Stock

NTLA

NMQ

$20.76

+$0.74

(3.7%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About Intellia Therapeutics Inc, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

News

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²